Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 50.06%-97.36M | ---- | 60.64%-720.49M | ---- | 79.96%-194.94M | ---- | -257.69%-1.83B | ---- | -236.27%-972.54M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -35.84%-16.73M | ---- | 33.10%-20.96M | ---- | -0.25%-12.32M | ---- | -109.51%-31.34M | ---- | -99.51%-12.29M |
| Attributable subsidiary (profit) loss | ---- | -25.02%8.91M | ---- | 21.90%28.75M | ---- | 347.01%11.88M | ---- | 239.08%23.58M | ---- | 84.64%2.66M |
| Impairment and provisions: | ---- | 21.12%77.86M | ---- | -60.44%255.66M | ---- | -65.70%64.29M | ---- | 276.16%646.29M | ---- | 303.51%187.4M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --17.75M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -3.91%66.78M | ---- | -65.40%191.88M | ---- | -68.74%69.49M | ---- | 664.19%554.55M | ---- | 11,351.37%222.33M |
| -Impairment of trade receivables (reversal) | ---- | 136.24%11.52M | ---- | -920.53%-34.36M | ---- | 17.36%-31.79M | ---- | -93.89%4.19M | ---- | -180.76%-38.46M |
| -Impairment of goodwill | ---- | ---- | ---- | 3.96%75.65M | ---- | 1,695.80%25.25M | ---- | 151.98%72.77M | ---- | --1.41M |
| -Other impairments and provisions | ---- | -133.11%-440K | ---- | -67.95%4.74M | ---- | -37.58%1.33M | ---- | 692.81%14.78M | ---- | 168.47%2.13M |
| Revaluation surplus: | ---- | -31.89%14.91M | ---- | -72.50%16.32M | ---- | 129.81%21.89M | ---- | 464.38%59.35M | ---- | 364.64%9.53M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---32.84M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | -31.89%14.91M | ---- | -17.17%49.16M | ---- | 129.81%21.89M | ---- | 464.38%59.35M | ---- | 364.64%9.53M |
| Asset sale loss (gain): | ---- | -11.34%344K | ---- | 103.26%509K | ---- | 102.52%388K | ---- | -5,827.11%-15.64M | ---- | -4,686.61%-15.41M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---16.58M | ---- | ---16.58M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -11.34%344K | ---- | -46.31%509K | ---- | -66.89%388K | ---- | 247.25%948K | ---- | 248.81%1.17M |
| Depreciation and amortization: | ---- | 31.55%402.03M | ---- | 39.46%631.76M | ---- | 48.08%305.61M | ---- | 55.97%453.02M | ---- | 51.20%206.38M |
| -Amortization of intangible assets | ---- | -43.90%7.38M | ---- | 45.12%29.03M | ---- | 98.46%13.16M | ---- | 227.08%20M | ---- | 247.30%6.63M |
| Financial expense | ---- | 8.19%141.08M | ---- | -1.04%258.66M | ---- | 20.23%130.4M | ---- | 29.30%261.38M | ---- | 28.09%108.46M |
| Special items | ---- | -59.56%1.15M | ---- | 258.61%9.62M | ---- | -77.99%2.84M | ---- | 127.80%2.68M | ---- | 2,107.31%12.91M |
| Operating profit before the change of operating capital | ---- | 61.26%532.19M | ---- | 206.63%459.83M | ---- | 169.79%330.03M | ---- | -124.40%-431.24M | ---- | -148.62%-472.91M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 162.91%67.53M | ---- | -96.86%26.44M | ---- | 35.77%-107.34M | ---- | 142.60%843.12M | ---- | 81.94%-167.13M |
| Accounts receivable (increase)decrease | ---- | -256.46%-376.13M | ---- | 17.04%922.04M | ---- | -41.19%240.39M | ---- | 131.92%787.81M | ---- | 127.68%408.79M |
| Accounts payable increase (decrease) | ---- | 58.25%-179.15M | ---- | -209.23%-716.56M | ---- | -4,131.55%-429.12M | ---- | 8.48%656.04M | ---- | -101.43%-10.14M |
| Special items for working capital changes | ---- | -134.37%-16.16M | ---- | 143.84%153.14M | ---- | 140.04%47.03M | ---- | -196.70%-349.3M | ---- | -191.28%-117.45M |
| Cash from business operations | ---- | -65.09%28.28M | ---- | -43.92%844.88M | ---- | 122.57%80.99M | ---- | 187.90%1.51B | ---- | 39.57%-358.84M |
| Other taxs | ---- | -37.56%-22.21M | ---- | 74.12%-25.42M | ---- | 80.03%-16.14M | ---- | 34.39%-98.2M | ---- | -3.13%-80.84M |
| Adjustment items of business operations | -169.61%-66.36M | ---- | 74.48%163.05M | ---- | 120.50%95.33M | ---- | --93.45M | ---- | ---464.95M | ---- |
| Net cash from operations | -169.61%-66.36M | -90.64%6.07M | 74.48%163.05M | -41.81%819.46M | 120.50%95.33M | 114.75%64.84M | --93.45M | 175.57%1.41B | ---464.95M | 34.59%-439.69M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 76.49%21.66M | ---- | -33.10%20.96M | ---- | -0.11%12.27M | ---- | 109.51%31.34M | ---- | 99.51%12.29M |
| Dividend received - investment | 168.09%49.96M | ---- | 185.86%11.76M | ---- | -55.98%18.63M | ---- | --4.12M | ---- | --42.33M | ---- |
| Decrease in deposits (increase) | ---- | -235.63%-348.71M | ---- | -37.48%93.52M | ---- | 274.10%257.1M | ---- | 131.11%149.58M | ---- | 13.69%-147.67M |
| Sale of fixed assets | 4,199.87%22.1M | ---- | ---- | -98.59%5.37M | 328.62%513.92K | 11.51%1.06M | ---- | 2,850.59%380.21M | --119.9K | --947K |
| Purchase of fixed assets | -14.98%-552.02M | 52.20%-269.49M | 13.30%-225.12M | 78.70%-674.38M | 68.21%-480.1M | 58.79%-563.73M | ---259.65M | -42.49%-3.17B | ---1.51B | -143.62%-1.37B |
| Purchase of intangible assets | ---- | -1,609.87%-66.5M | ---- | 76.24%-10.26M | ---- | 89.80%-3.89M | ---- | -284.15%-43.17M | ---- | -479.44%-38.14M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --38.19M | ---- | --38.19M |
| Recovery of cash from investments | ---- | ---- | ---- | -26.71%8.59B | -73.11%6.19M | -8.01%4.83B | ---- | 125.65%11.72B | --23M | 377.09%5.25B |
| Cash on investment | ---- | 81.61%-1.03B | ---100.54M | 23.02%-9.05B | ---- | 17.01%-5.61B | ---- | -125.64%-11.75B | ---49M | -395.21%-6.76B |
| Other items in the investment business | 2.77%-875.11M | ---- | -40.53%-1.18B | ---- | 23.82%-900.05M | ---- | ---837.37M | ---- | ---1.18B | ---- |
| Net cash from investment operations | -0.02%-1.36B | -56.35%-1.7B | -36.40%-1.49B | 61.35%-1.02B | 49.36%-1.35B | 64.09%-1.08B | ---1.09B | -1.75%-2.64B | ---2.68B | -190.59%-3.02B |
| Net cash before financing | -12.86%-1.42B | -65.70%-1.69B | -32.84%-1.33B | 83.66%-201.49M | 59.89%-1.26B | 70.53%-1.02B | ---999.45M | 72.35%-1.23B | ---3.14B | -102.14%-3.46B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 1.27%5.16B | -9.76%3.3B | 9.82%2.09B | -32.72%6.66B | -38.29%5.09B | -49.39%3.66B | --1.9B | 81.07%9.89B | --8.25B | 197.89%7.22B |
| Refund | 17.07%-4.36B | 25.35%-2.64B | 19.73%-1.43B | -9.14%-7.31B | -22.77%-5.26B | -7.88%-3.54B | ---1.78B | -237.00%-6.7B | ---4.28B | -290.61%-3.28B |
| Issuing shares | ---- | --1.54B | ---- | --462.2M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 13.09%-98.73M | ---- | -9.25%-239.34M | ---- | -10.95%-113.6M | ---- | -84.70%-219.08M | ---- | -91.53%-102.39M |
| Dividends paid - financing | 14.33%-161.63M | ---- | 26.84%-47.33M | -5.27%-6.01M | -14.30%-188.66M | 25.19%-4.27M | ---64.69M | 95.58%-5.71M | ---165.05M | 45.16%-5.71M |
| Absorb investment income | 213.05%1.65B | ---- | 678.49%1.43B | -27.86%93.06M | 433.83%528.49M | 70.31%143.06M | --184.2M | --129M | --99M | --84M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -219.01%-38.28M | ---- | ---38.28M |
| Other items of the financing business | 9.44%-265.64M | -144.39%-171.07M | -1,024.93%-50.36M | --385.43M | -97.18%-293.33M | --385.43M | ---4.48M | ---- | ---148.77M | ---- |
| Net cash from financing operations | 1,821.76%2.03B | 429.17%1.85B | 752.48%1.99B | -109.44%-250.07M | -103.13%-117.63M | -90.62%348.79M | --233.93M | -48.60%2.65B | --3.76B | 0.96%3.72B |
| Effect of rate | -509.59%-11.41M | -92.34%-2.08M | 596.59%4.11M | -96.78%415K | -133.41%-1.87M | -142.14%-1.08M | ---827.5K | 1,125.81%12.87M | --5.6M | 966.39%2.57M |
| Net Cash | 143.85%603.87M | 123.31%156.35M | 187.08%666.6M | -131.88%-451.56M | -323.27%-1.38B | -357.23%-670.7M | ---765.52M | 103.74%1.42B | --616.78M | -86.79%260.74M |
| Begining period cash | -15.97%2.51B | -15.97%2.51B | -15.97%2.51B | 93.45%2.96B | 95.27%2.99B | 95.27%2.99B | --2.99B | 83.57%1.53B | --1.53B | 83.57%1.53B |
| Cash at the end | 92.98%3.1B | 15.09%2.66B | 43.25%3.18B | -15.25%2.51B | -25.30%1.61B | 29.12%2.31B | --2.22B | 93.45%2.96B | --2.15B | -36.13%1.79B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.